Get up to date with the most relevant advances in allergen-specific immunotherapy (AIT), which have allowed the development of pioneering treatments adapted to the needs of each patient"

Advances in molecular diagnostics in pediatrics are particularly promising, as in recent years they have made it possible to fine-tune the patient's sensitization profile to the millimeter. This inevitably leads to a favorable framework for action, with a more personalized allergen-specific immunotherapy (AIT) adapted to the allergic conditions of each patient. The role of the specialists in the whole process of diagnosis and recommendation of the avoidance diet is crucial, so their level of updating must be high and constant.

A deeper knowledge of immune development in children allows us to understand the evolution of certain pathologies in childhood in later years. A team of teachers specialized in Pediatric Allergology has developed a complete syllabus that compiles not only the advances and developments in this field, but also its impact on clinical practice. In this way, the specialist obtains a necessary pragmatic vision from professionals widely versed in the field of allergies and immunology, thereby perfecting their own work methodologies and approach to each subject treated.

Throughout the program, the most frequent consultations in the Pediatric Allergology area as well as the rare pathologies that usually occur in childhood will be discussed. The specialist will cover, through high quality multimedia content, cutaneous allergic manifestations, food allergens, asthmatic pathologies in children and infants, frequent atopic dermatitis and other essential topics for a comprehensive and exhaustive update in a far-reaching clinical field.

All this, in addition, with the advantage of having the characteristic flexibility of a 100% online format. TECH is aware of how complicated it can be to combine a program of these characteristics with the most demanding medical activity, so it has eliminated both classroom classes and fixed schedules. It is the specialists themselves who decide how to distribute all the teaching content, being able to download it and study it from any device with an internet connection.

Get up to date with a team of highly committed teachers, who have compiled the most important practical developments in allergology protocols in this program"

This Master's Degree in Pediatric Allergology contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Pediatric Allergology
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self assessment can be used to improve learning
• Its special emphasis on innovative methodologies 
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

Access a virtual classroom that will be available 24 hours a day, full of high quality multimedia content to further deepen all facets of Pediatric Allergology"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this training program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise throughout the program. For this purpose, the student will be assisted by an innovative interactive video system created by renowned and experienced experts.  

You will be able to decide where, when and how to take on the entire course load, being able to study the entire syllabus from the comfort of your tablet or even smartphone of choice"

It delves into new developments in drug allergy, including antibiotic allergy, vaccines and drug desensitization"

In order to facilitate as much as possible the study work of the specialist, TECH has incorporated the pedagogical methodology of Relearning in the development of this Master's Degree. This technique has proven to be very effective and allows the specialist to naturally assume the most important concepts and keys in pediatric allergies. This is achieved by naturally reiterating these concepts throughout the syllabus, which also results in a significant reduction in the number of study hours required to pass the program.

Benefit from the most academically successful teaching methodology and update your knowledge in Pediatric Allergology in a fast, efficient and exhaustive way”

Module 1. Allergic Disease

1.1. Epidemiology

1.1.1. Prevalence of Allergic Disease
1.1.2. Genetic, Epigenetics and Environmental Factors

1.2. Immune System Development

1.2.1. Fetal Immunity
1.2.2. Immune System Maturation

1.3. Inborn Errors of the Immune System

1.3.1. Main Primary Immunodeficiencies
1.3.2. Warning Signs
1.3.3. Allergic Manifestations
1.3.4. Diagnostic Approximation
1.3.5. Treatment

1.4. Allergic Sensitization

1.4.1. Cells Involved
1.4.2. Inflammatory Mediators
1.4.3. Sensitization Pathways

1.5. Tolerance Mechanisms

1.5.1. Factors Influencing the Achievement of Tolerance
1.5.2. Immunological Basis

1.6. Atopic Gait
1.7. General Evaluation of the Allergic Patient

1.7.1. General Medical Records
1.7.2. Findings on Physical Examination Suggestive of Atopy
1.7.3. General Notions of Diagnostic Tests in Allergy

1.8. Terminology

1.8.1. Allergy. Sensitization
1.8.2. Allergenic Source. Allergens. Cross-Reactivity

1.9. Molecular Diagnoses

1.9.1. Current Indications and Limitations
1.9.2. Approach to Molecular Diagnostics
1.9.3. Most Relevant Allergen Families

1.10. Respiratory Function Tests in Children

1.10.1. Spirometry and Bronchodilation Test
1.10.2. Bronchial Provocation Tests
1.10.3. Tests for Measuring Eosinophilic Inflammation
1.10.4. Others Diagnostic Methods

Module 2. Allergic Cutaneous, Systemic and Respiratory Manifestations

2.1. Acute Urticaria

2.1.1. Pathophysiology
2.1.2. Frequent Etiology in the Child
2.1.3. Anamnesis and Physical Examination
2.1.4. The Role of Antihistamines in the Treatment of Acute Urticaria

2.2. Chronic Urticaria

2.2.1. Etiopathogenesis
2.2.2. Classification
2.2.3. Diagnosis
2.2.4. Treatment

2.3. Acute Angioedema

2.3.1. Pathophysiology
2.3.2. Frequent Etiology in the Child
2.3.3. Anamnesis and Physical Examination
2.3.4. Treatment

2.4. Recurrent Angioedema

2.4.1. Etiopathogenesis
2.4.2. Classification
2.4.3. Diagnosis
2.4.4. Treatment

2.5. Angioedema due to C1 Inhibitor Deficiency

2.5.1. Etiopathogenesis
2.5.2. Classification
2.5.3. Diagnosis
2.5.4. Treatment

2.6. Anaphylaxis

2.6.1. Pathophysiology
2.6.2. Etiology
2.6.3. Treatment
2.6.4. Prevention

2.7. Idiopathic Anaphylaxis

2.7.1. Differential Diagnosis
2.7.2. Diagnosis
2.7.3. Treatment

2.8. Exercise-Induced Anaphylaxis

2.8.1. Etiopathogenesis
2.8.2. Classification
2.8.3. Diagnosis
2.8.4. Treatment

2.9. Mastocytosis in Children

2.9.1. Prevalence
2.9.2. Mastocytoma
2.9.3. Urticaria Pigmentosa
2.9.4. Diagnosis and Monitoring
2.9.5. Treatment

2.10. Treatment of Asthma Attack

2.10.1. Severity Assessment
2.10.2. Treatment Algorithm
2.10.3. Response Assessment and Discharge Recommendations

Module 3. Food Allergy and the Most Frequent Food Allergens in the Pediatric Age Group

3.1. Approach to the Patient with Food Allergy

3.1.1. Medical History
3.1.2. Diagnostic Generalities

3.1.2.1. Skin Tests
3.1.2.2. Oral Tolerance Tests
3.1.2.3. In Vitro Determination

3.1.3. Treatment of Food Allergy

3.1.3.1. Avoidance
3.1.3.2. Active Treatments

3.2. Food Allergen Approach

3.2.1. General Aspects
3.2.2. Protein Stability
3.2.3. Effects of Processing
3.2.4. The Digestive System as an Immune Organ

3.3. Allergy to Cow's Milk Proteins

3.3.1. Epidemiology
3.3.2. Natural History
3.3.3. Diagnosis

3.4. Avoidance Therapy in Cow's Milk Protein Allergy

3.4.1. Hydrolyzed Formulas
3.4.2. Vegetable Formulas

3.5. Oral Immunotherapy to Cow's Milk Proteins

3.5.1. Indications
3.5.2. Rapid Protocol
3.5.3. Slow Protocol for Anaphylactic Patients

3.6. Egg Allergy

3.6.1. Epidemiology
3.6.2. Natural History
3.6.3. Diagnosis
3.6.4. Treatment

3.7. Oral Egg Immunotherapy

3.7.1. Indications
3.7.2. Tolerance Induction with Raw Egg
3.7.3. Tolerance Induction with Boiled Egg
3.7.4. Tolerance Induction with Baking

3.8. Non-IgE-Mediated Allergies

3.8.1. Allergic Proctocolitis
3.8.2. Food Protein-Induced Enterocolitis
3.8.3. Food Protein Enteropathy

3.9. Nutritional Aspects of Food Allergy
3.10. Possible Interventions in the Primary Prevention of Cow's Milk and Egg Allergy

Module 4. Other Allergens Causing Food Allergy in Childhood

4.1. Nut and Seed Allergy

4.1.1. Epidemiology
4.1.2. Natural History
4.1.3. Diagnosis
4.1.4. Treatment

4.2. Allergy to Shellfish and Fish

4.2.1. Shellfish Allergy

4.2.1.1. Epidemiology
4.2.1.2. Natural History
4.2.1.3. Diagnosis
4.2.1.4. Treatment

4.2.2. Fish Allergy

4.2.2.1. Epidemiology
4.2.2.2. Natural History
4.2.2.3. Diagnosis
4.2.2.4. Treatment

4.3. Legume Allergy

4.3.1. Epidemiology
4.3.2. Natural History
4.3.3. Diagnosis
4.3.4. Treatment

4.4. Oral Allergy Syndrome

4.4.1. Epidemiology
4.4.2. Natural History
4.4.3. Diagnosis
4.4.4. Treatment
4.4.5. Latex-Fruit Syndrome

4.5. LTP Sensitization Syndrome

4.5.1. Epidemiology
4.5.2. Natural History
4.5.3. Diagnosis
4.5.4. Treatment

4.6. Allergy to Cereals

4.6.1. Epidemiology
4.6.2. Natural History
4.6.3. Diagnosis
4.6.4. Treatment

4.7. Allergy to Food Additives and Preservatives
4.8. Induction of Tolerance to Other Foods

4.8.1. Current Evidence
4.8.2. New Forms of Immunotherapy with Food

4.9. Eosinophilic Esophagitis and its Relation to Food Allergy
4.10. Legislation on Allergen Labeling in the Food Industry

4.10.1. Recommendations to the Patient

Module 5. Drug Allergies

5.1. Adverse Reactions to Medications

5.1.1. Classification of Hypersensitivity Reactions
5.1.2. Drugs as Allergens

5.2. Diagnostic Approximation

5.2.1. Peculiarities in the Child
5.2.2. Medical History

5.3. Allergy to beta-lactams

5.3.1. Penicillin. Chemical Structure and Classification
5.3.2. Side Chain Allergens
5.3.3. Allergens by Central Core
5.3.4. Medical History
5.3.5. Diagnosis
5.3.6. Avoidance Recommendations According to Results
5.3.7. Allergy to Cephalosporins and Cross-Reactivity with Penicillin Derivatives

5.4. Allergy to NSAIDs

5.4.1. Classification of NSAIDs
5.4.2. Types of Reactions to NSAIDs
5.4.3. Diagnosis
5.4.4. Avoidance Recommendations
5.4.5. Possible Alternative Drugs in Children

5.5. Allergy to Other Antibiotics

5.5.1. Macrolides
5.5.2. Sulfamides
5.5.3. Quinolones
5.5.4. Aminoglycosides
5.5.5. Glycopeptides

5.6. Allergy to Local Anesthetics and Perioperative Anaphylaxis

5.6.1. Suspicion of Perioperative Allergic Reaction
5.6.2. Tests to be Performed for Screening of the Responsible Drug
5.6.3. Suspicion of Allergy to Local Anesthetics

5.7. Vaccine Allergy

5.7.1. Types of Vaccine Reactions
5.7.2. Vaccine Content
5.7.3. Epidemiology of Vaccine Allergic Reactions
5.7.4. Reactions that May Simulate Allergic Reaction After Vaccination
5.7.5. Diagnosis of Allergy to Vaccines
5.7.6. Vaccination Recommendations for those Allergic to any of the Following Components

5.8. Drug Desensitization

5.8.1. Introduction
5.8.2. Desensitization Mechanism
5.8.3. Risk Assessment
5.8.4. Desensitization Protocols

5.9. Severe Manifestations of Non-IgE-Mediated Reactions to Drugs

5.9.1. DRESS
5.9.2. Sd. Stevens-Johnson
5.9.3. Acute Generalized Exanthematous Pustulosis
5.9.4. Other Systemic Manifestations

5.10. Approach to Diagnosis in Severe Non-IgE Mediated Reactions

Module 6. Asthma in the Infant and Young Child 

6.1. The Debate Between Recurrent Wheezing and Asthma
6.2. Prevalence Around the World and in Spain BORRAR
6.3. Natural History

6.3.1. Tucson Phenotypes
6.3.2. Phenotypes by Triggers
6.3.3. IPA Index

6.4. Etiopathogenesis
6.5. Risk Factors

6.5.1. From the Guest
6.5.2. Perinatal
6.5.3. Environmental

6.6. Diagnosis

6.6.1. Clinical and Anamnesis
6.6.2. Complementary Tests
6.6.3. Assessment of Severity
6.6.4. Assessment of Control

6.7. Differential Diagnosis
6.8. Pharmacological Treatment

6.8.1. Treatment Steps
6.8.2. Drugs Available for Asthma in Children under 3 Years of Age

6.9. Non-Pharmacological Treatment

6.9.1. Environmental Measurements
6.9.2. Immunizations

6.10. Inhaled Therapy in Children

6.10.1. Fundamentals of Inhaled Therapy: Particle Characteristics and Pulmonary Deposition
6.10.2. Correct Use of Inhalers According to Age

Module 7. Asthma in Older Children and Adolescents 

7.1. Prevalence
7.2. Pathophysiology

7.2.1. Cells Involved in Asthma
7.2.2. Inflammatory Mediators
7.2.3. Airway Obstruction Mechanisms

7.3. Phenotypes of Asthma

7.3.1. Th2 Phenotype
7.3.2. Non-Th2 Phenotype

7.4. Diagnosis

7.4.1. Pulmonary Function
7.4.2. Reversibility
7.4.3. Other Markers of Inflammation

7.5. Differential Diagnosis
7.6. Comorbidities

7.6.1. Rhinosinusitis
7.6.2. Sleep Apnea-Hypopnea Syndrome (SAHS)
7.6.3. Gastroesophageal Reflux
7.6.4. Obesity
7.6.5. Atopic Dermatitis

7.7. Pharmacological Treatment

7.7.1. Treatment Steps
7.7.2. Available Drugs

7.8. Non-Pharmacological Treatment

7.8.1. Asthma Education

7.9. Uncontrolled Severe Asthma
7.10. Approved Biological Treatments in the Pediatric Population

Module 8. Allergen-Specific Immunotherapy (AIT)

8.1. Immunotherapy
8.2. Mechanism of Action
8.3. Content of Allergenic Vaccines

8.3.1. Types of Extracts
8.3.2. Adjuvants

8.4. Indications and Contraindications of Immunotherapy
8.5. Effectiveness of Immunotherapy

8.5.1. Short-Term Efficacy
8.5.2. Long-Term Efficacy
8.5.3. Improving Efficiency through Molecular Diagnostics
8.5.4. Allergen Mixtures and Immunotherapies

8.6. Safety of Immunotherapy

8.6.1. Local Reactions
8.6.2. Systemic Reactions

8.7. Types of Immunotherapy

8.7.1. By Route of Administration
8.7.2. By Guidelines of Administration
8.7.3. By Type of Allergen

8.8. Practical Management of Immunotherapy

8.8.1. Starting Guidelines
8.8.2. Duration of Immunotherapy
8.8.3. Dose Adjustments

8.9. Monitoring and Adherence

8.9.1. Evaluation of the Response
8.9.2. How to Improve Adherence

8.10. Advances in Immunotherapy

8.10.1. New Adjuvants
8.10.2. New Routes of Administration

Module 9. Eye-Nasal Allergy 

9.1. Prevalence

9.1.1. Quality of Life of the Patient with Eye-Nasal Allergy
9.1.2. Socio-Economic Cost

9.2. Etiopathogenesis
9.3. Diagnosis of Rhinoconjunctivitis

9.3.1. Clinical Symptoms
9.3.2. Etiological

9.4. Differential Diagnosis
9.5. Pharmacological Treatment of Allergic Rhinoconjunctivitis
9.6. Health Education for Allergen Avoidance
9.7. Pollen Allergy

9.7.1. Epidemiology
9.7.2. The Pollen Molecule
9.7.3. Pollen Classification
9.7.4. Geographical Distribution of Pollens
9.7.5. Main Allergens
9.7.6. Molecule Diagnostics in Pollen Allergy

9.8. Allergy to Animal Epithelia

9.8.1. Epidemiology
9.8.2. Main Allergens
9.8.3. Molecular Diagnosis in Allergy to Animal Epithelia

9.9. Dust Mite Allergy

9.9.1. Epidemiology
9.9.2. Mites
9.9.3. Distribution of Mites according to Climate
9.9.4. Main Allergens
9.9.5. Molecular Diagnoses

9.10. Allergy to Damp Fungi

9.10.1. Epidemiology
9.10.2. Moisture Mould
9.10.3. Distribution of Fungi according to Climate
9.10.4. Main Allergens
9.10.5. Molecular Diagnoses

Module 10. Atopic Dermatitis

10.1. Etiopathogenesis

10.1.1. Predisposing Factors
10.1.2. Skin Barrier Dysfunction
10.1.3. Immunological Alterations

10.2. Diagnosis

10.2.1. Clinical Diagnosis
10.2.2. Severity Assessment
10.2.3. Differential Diagnosis

10.3. Complications of Atopic Dermatitis

10.3.1. Infectious
10.3.2. Non-Infectious

10.4. General Guidelines for Atopic Skin Care

10.4.1. Hygiene
10.4.2. Feeding
10.4.3. Dresses and Clothing
10.4.4. Environmental Guidelines

10.5. Treatment Objectives

10.5.1. Treatment of the Inflammation
10.5.2. Itching Control
10.5.3. Restoration of the Skin Barrier

10.6. Topical Drugs

10.6.1. Emollients
10.6.2. Topical Corticosteroids
10.6.3. Use of Topical Immunomodulators

10.7. Systemic Treatment

10.7.1. Antihistamines
10.7.2. Systemic Corticoids
10.7.3. Systemic Immunomodulators
10.7.4. Biological Drugs

10.8. Treatment of Infectious Complications

10.8.1. Infections of Viral Etiology
10.8.2. Infections of Bacterial Etiology

10.9. When and How to Assess Food Allergy as a Cause of Atopic Dermatitis
10.10. Contact Dermatitis

It delves into the most important treatments, diagnoses and advances in pediatric allergies thanks to the most rigorous multimedia content, developed by the teaching staff itself”